Nawah Scientific and Deef Pharma Signs a Major Contract to Develop Medical Products for the Saudi Market
Riyadh, on 21.10.2024
Nawah Scientific, a leading regional player in pharmaceutical formulation and drug development, is proud to announce the signing of a major contract with Deef Pharma, one of Saudi Arabia’s fastest-growing pharmaceutical companies. The agreement marks the beginning of a strategic collaboration aimed at developing a range of essential medical products tailored to the needs of the Saudi market.
The partnership between Nawah Scientific and Deef Pharma will leverage Nawah’s expertise in pharmaceutical generic formulation, research and development (R&D), and Deef Pharma’s growing presence in the Saudi market. Together, the companies will address the evolving needs of healthcare in Saudi Arabia, with a focus on delivering high-quality, innovative, and affordable treatments for patients.
“We are thrilled to be partnering with Deef Pharma on this exciting project,” said Dr. Omar Sakr, CEO of Nawah Scientific. “This collaboration underscores Nawah’s position as a leader in the Middle East for pharmaceutical development, and it aligns perfectly with our mission to support healthcare systems across the region. With Deef Pharma’s rapid growth and ambition, we are confident that together we will make a significant impact on the Saudi healthcare landscape.”
Nawah Scientific, known for its cutting-edge capabilities in drug formulation, has built a solid reputation as a trusted partner for pharmaceutical companies throughout the Middle East and North Africa. The company’s commitment to innovation and excellence has positioned it as a leader in the R&D sector, helping to create accessible and effective treatments for various markets.
On the other hand, Deef Pharma focuses on national & regional patients’ well-being and hence its vision is to bridge gaps that might face patients, healthcare professionals, pharma corporates and governments in their journey. Deef Pharma is well on its way to becoming a key player not only in the local Saudi market but also in the GCC and regional markets. This partnership with Nawah Scientific will enable Deef to accelerate its development of high-demand medical products and fulfill its vision of delivering world-class healthcare solutions to the Kingdom and the region. “We are honoured to collaborate with Nawah Scientific, a true regional leader in pharmaceutical R&D,” said Dr. Ashraf Abu Arrah, CEO of Deef Pharma. “This agreement is a significant step forward for Deef Pharma as we work toward expanding our portfolio of medical products and making a meaningful contribution to Saudi Arabia’s healthcare sector.”
The newly signed contract paves the way for a productive and long-lasting partnership between the two companies, contributing to the advancement of healthcare in the Kingdom of Saudi Arabia and strengthening the regional pharmaceutical industry.
